International Journal of Drug Regulatory Affairs (IJDRA)
  • Year: 2019
  • Volume: 7
  • Issue: 1

Nanoparticles and target Drug delivery for cancer treatment: A Comprehensive review

1Research Analyst, PHIS, Middlesex Essex Tp, Iselin, NJ, USA

2Healthcare service Manager, Patel Healthcare LLC, USA

*Corresponding author Tel.: +1 (908) 821–7771; E-mail address: nandishpathak@gmail.com (Nandish Pathak).

Online published on 17 September, 2019.

Abstract

In the healthcare industry, the biggest challenges are cancer. However, there are several drugs are available for the treatment of cancer. In these treatments cure cancer affecting the collateral toxicity to healthy cells. In addition to the drug delivery systems in cancer have many barriers such as immune clearance or hepatic, renal. Thus, to improve treatment and overcome these problems the nanoparticle-loaded drug is one the solution. Moreover, the nanomedicine opens a new era in the healthcare industry as an effective drug delivery system. The nanoparticle drug delivery has significant characteristics for treatments such as less toxicity, high loading capacity, and stability of the drug. This review aims to present the conventional cancer treatment and elaborate on the nanoparticle-loaded drug delivery system to overcome the side effects of the conventional treatment.

Keywords

Targeted Drug delivery systems, Nanoparticles, cancer treatment